ValGenesis to Showcase Process Lifecycle Suite at BioProcessing Summit Europe 2026

Estimated Read Time: 3 minutes

ValGenesis Inc., a provider of digital validation lifecycle management solutions for the life sciences industry, has announced it will showcase its Process Lifecycle Suite at the upcoming BioProcessing Summit Europe 2026.

The industry event will take place from March 10–12, 2026, in Barcelona, Spain, bringing together bioprocessing experts, scientists, and technology leaders focused on advancing modern biomanufacturing and pharmaceutical innovation.

Advancing Digital Process Lifecycle Management

During the summit, ValGenesis will demonstrate how its Process Lifecycle Suite—part of the company’s Smart GxP™ platform—helps pharmaceutical and biotechnology organizations streamline validation and manufacturing processes across the entire product lifecycle.

Many life sciences companies continue to rely on fragmented systems and manual workflows for lifecycle management. The platform aims to address these challenges by connecting development, validation, and ongoing process monitoring into a unified digital framework.

Improving Compliance and Operational Efficiency

At Booth No. 35, attendees will have the opportunity to explore strategies for implementing end-to-end digital lifecycle management, maintaining inspection readiness, and scaling validation activities across global manufacturing networks.

The solution supports continuous compliance by improving traceability, strengthening quality oversight, and enabling organizations to maintain a consistent state of operational control throughout drug development and production.

Supporting Innovation in Biomanufacturing

As regulatory expectations increase and advanced therapies such as cell and gene treatments expand, organizations are seeking technology platforms capable of managing complex validation requirements efficiently.

ValGenesis’ participation at BioProcessing Summit Europe highlights the growing role of AI-enabled digital validation systems in accelerating innovation while reducing operational risk in life sciences manufacturing environments.

About ValGenesis

ValGenesis provides enterprise digital validation solutions designed to help life sciences companies modernize commissioning, qualification, and validation processes. Through its Smart GxP™ platform, the company enables organizations worldwide to enhance compliance, improve efficiency, and accelerate the delivery of high-quality therapies to market.

More information about ValGenesis solutions and event participation can be found on the company’s official newsroom page.